Allogeneic bone marrow transplantation (BMT) for acquired severe aplastic anaemia (SAA) in children

A. Locasciulli, J. Vossen, A. Bacigalupo, J. Hows, M. T. VanLint, E. Gluckman, C. Nissen, S. McCann, M. De Planque, L. Van'tVeer, A. Ragavashar, A. Marin

Research output: Contribution to journalArticle

Abstract

The SAA Registry of the EBMT now contains data on 171 children younger than 15 years of age with acquired SAA and undergoing BMT between 1970 and 1988. The overall actuarial survival is 63% at 10 years. In a multivariate Cox analysis, the year of transplant was the most important prognostic factor with a significant advantage for children grafted in 1984-88 (81%) vs. 1981-83 (67%) and 1970-80 (41%) (p=0.02). Cyclosporine A given for GVHD prophylaxis, no treatment before transplant and an interval

Original languageEnglish
Pages (from-to)123-125
Number of pages3
JournalBone Marrow Transplantation
Volume4
Issue numberSUPPL. 4
Publication statusPublished - 1989

Fingerprint

Aplastic Anemia
Homologous Transplantation
Bone Marrow Transplantation
Transplants
Cyclosporine
Registries
Multivariate Analysis
Therapeutics

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Locasciulli, A., Vossen, J., Bacigalupo, A., Hows, J., VanLint, M. T., Gluckman, E., ... Marin, A. (1989). Allogeneic bone marrow transplantation (BMT) for acquired severe aplastic anaemia (SAA) in children. Bone Marrow Transplantation, 4(SUPPL. 4), 123-125.

Allogeneic bone marrow transplantation (BMT) for acquired severe aplastic anaemia (SAA) in children. / Locasciulli, A.; Vossen, J.; Bacigalupo, A.; Hows, J.; VanLint, M. T.; Gluckman, E.; Nissen, C.; McCann, S.; De Planque, M.; Van'tVeer, L.; Ragavashar, A.; Marin, A.

In: Bone Marrow Transplantation, Vol. 4, No. SUPPL. 4, 1989, p. 123-125.

Research output: Contribution to journalArticle

Locasciulli, A, Vossen, J, Bacigalupo, A, Hows, J, VanLint, MT, Gluckman, E, Nissen, C, McCann, S, De Planque, M, Van'tVeer, L, Ragavashar, A & Marin, A 1989, 'Allogeneic bone marrow transplantation (BMT) for acquired severe aplastic anaemia (SAA) in children', Bone Marrow Transplantation, vol. 4, no. SUPPL. 4, pp. 123-125.
Locasciulli A, Vossen J, Bacigalupo A, Hows J, VanLint MT, Gluckman E et al. Allogeneic bone marrow transplantation (BMT) for acquired severe aplastic anaemia (SAA) in children. Bone Marrow Transplantation. 1989;4(SUPPL. 4):123-125.
Locasciulli, A. ; Vossen, J. ; Bacigalupo, A. ; Hows, J. ; VanLint, M. T. ; Gluckman, E. ; Nissen, C. ; McCann, S. ; De Planque, M. ; Van'tVeer, L. ; Ragavashar, A. ; Marin, A. / Allogeneic bone marrow transplantation (BMT) for acquired severe aplastic anaemia (SAA) in children. In: Bone Marrow Transplantation. 1989 ; Vol. 4, No. SUPPL. 4. pp. 123-125.
@article{579e4fb05f114a94930f164ed9db32b5,
title = "Allogeneic bone marrow transplantation (BMT) for acquired severe aplastic anaemia (SAA) in children",
abstract = "The SAA Registry of the EBMT now contains data on 171 children younger than 15 years of age with acquired SAA and undergoing BMT between 1970 and 1988. The overall actuarial survival is 63{\%} at 10 years. In a multivariate Cox analysis, the year of transplant was the most important prognostic factor with a significant advantage for children grafted in 1984-88 (81{\%}) vs. 1981-83 (67{\%}) and 1970-80 (41{\%}) (p=0.02). Cyclosporine A given for GVHD prophylaxis, no treatment before transplant and an interval",
author = "A. Locasciulli and J. Vossen and A. Bacigalupo and J. Hows and VanLint, {M. T.} and E. Gluckman and C. Nissen and S. McCann and {De Planque}, M. and L. Van'tVeer and A. Ragavashar and A. Marin",
year = "1989",
language = "English",
volume = "4",
pages = "123--125",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "SUPPL. 4",

}

TY - JOUR

T1 - Allogeneic bone marrow transplantation (BMT) for acquired severe aplastic anaemia (SAA) in children

AU - Locasciulli, A.

AU - Vossen, J.

AU - Bacigalupo, A.

AU - Hows, J.

AU - VanLint, M. T.

AU - Gluckman, E.

AU - Nissen, C.

AU - McCann, S.

AU - De Planque, M.

AU - Van'tVeer, L.

AU - Ragavashar, A.

AU - Marin, A.

PY - 1989

Y1 - 1989

N2 - The SAA Registry of the EBMT now contains data on 171 children younger than 15 years of age with acquired SAA and undergoing BMT between 1970 and 1988. The overall actuarial survival is 63% at 10 years. In a multivariate Cox analysis, the year of transplant was the most important prognostic factor with a significant advantage for children grafted in 1984-88 (81%) vs. 1981-83 (67%) and 1970-80 (41%) (p=0.02). Cyclosporine A given for GVHD prophylaxis, no treatment before transplant and an interval

AB - The SAA Registry of the EBMT now contains data on 171 children younger than 15 years of age with acquired SAA and undergoing BMT between 1970 and 1988. The overall actuarial survival is 63% at 10 years. In a multivariate Cox analysis, the year of transplant was the most important prognostic factor with a significant advantage for children grafted in 1984-88 (81%) vs. 1981-83 (67%) and 1970-80 (41%) (p=0.02). Cyclosporine A given for GVHD prophylaxis, no treatment before transplant and an interval

UR - http://www.scopus.com/inward/record.url?scp=0024955817&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024955817&partnerID=8YFLogxK

M3 - Article

C2 - 2697423

AN - SCOPUS:0024955817

VL - 4

SP - 123

EP - 125

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - SUPPL. 4

ER -